• Je něco špatně v tomto záznamu ?

Effects of cytochrome P450 inhibitors on peroxidase activity

M. Martinkova, B. Kubickova, M. Stiborova,

. 2012 ; 33 Suppl 3 () : 33-40.

Jazyk angličtina Země Švédsko

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024004

OBJECTIVES: Of several enzymes metabolizing xenobiotics, cytochrome P450 (CYP) and peroxidase enzymes seem to be most important. One of the major challenges in studies investigating metabolism of xenobiotics is to resolve which of these two groups of enzymes is predominant to metabolize individual xenobiotic compounds. Utilization of selective inhibitors of CYP and peroxidase enzymes might be a useful tool to identify the contribution of these enzymes to metabolism of xenobiotics in samples, where both types of enzymes are present. The aim of this study was to investigate specificities of several known CYP inhibitors to these enzymes; whether they inhibit only the CYP enzymes and do not inhibit peroxidases. METHODS: Since the oxidation of o-anisidine catalyzed by a model peroxidase used, horseradish peroxidase (HRP), is a two-substrate reaction, the inhibition potential of tested chemicals was studied with respect to both peroxidase substrates, o-anisidine and hydrogen peroxide. Initial velocities of o-anisidine oxidation by HRP under various conditions were determined spectrophotometrically. RESULTS: The CYP inhibitors metyrapone, troleandomycine, disulfiram, sulfaphenazole, quinidine and 1-aminobenzotriazole do not inhibit o-anisidine oxidation catalyzed by HRP. In contrast, ketoconazole, diethyldithiocarbamate, ellipticine, α-naphtoflavone, proadifen SKF525A, piperonylbutoxide, were found to inhibit not only the CYPs, but also the HRP-mediated oxidation of o-anisidine. Interestingly, α-naphtoflavone inhibits oxidation of o-anisidine by HRP with respect to H2O2, but not with respect to o-anisidine. Diethyldithiocarbamate is the most potent peroxidase inhibitor of o-anisidine oxidation with Ki with respect to o-anisidine of 10 μM and Ki with respect to H2O2 of 60 μM, being even the better peroxidase inhibitor than the classical "peroxidase inhibitor" - propyl gallate (Ki with respect to o-anisidine of 60 μM and Ki with respect to H2O2 of 750 μM). CONCLUSIONS: The results of the present study demonstrate that 1-aminobenzotriazole, a potent inhibitor of various CYP enzymes, seems to be the best candidate suitable for utilization in studies evaluating participation of CYP enzymes in metabolism of xenobiotics in various complex biological materials containing both CYP and peroxidase enzymes. Moreover, precaution to prevent misinterpretation of results is necessary in cases when proadifen SKF525A, piperonylbutoxide, diethyldithiocarbamate, ketoconazole, α-naphtoflavone and ellipticine are used in similar studies (as CYP inhibitors in various complex biological materials containing both CYP and peroxidase enzymes), since these chemicals can except of CYP enzymes inhibit also peroxidase-mediated reactions.

000      
00000naa a2200000 a 4500
001      
bmc13024004
003      
CZ-PrNML
005      
20131002123056.0
007      
ta
008      
130703s2012 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)23353841
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Martinkova, Marketa $u Department of Biochemistry, Charles University, Prague, Czech Republic.
245    10
$a Effects of cytochrome P450 inhibitors on peroxidase activity / $c M. Martinkova, B. Kubickova, M. Stiborova,
520    9_
$a OBJECTIVES: Of several enzymes metabolizing xenobiotics, cytochrome P450 (CYP) and peroxidase enzymes seem to be most important. One of the major challenges in studies investigating metabolism of xenobiotics is to resolve which of these two groups of enzymes is predominant to metabolize individual xenobiotic compounds. Utilization of selective inhibitors of CYP and peroxidase enzymes might be a useful tool to identify the contribution of these enzymes to metabolism of xenobiotics in samples, where both types of enzymes are present. The aim of this study was to investigate specificities of several known CYP inhibitors to these enzymes; whether they inhibit only the CYP enzymes and do not inhibit peroxidases. METHODS: Since the oxidation of o-anisidine catalyzed by a model peroxidase used, horseradish peroxidase (HRP), is a two-substrate reaction, the inhibition potential of tested chemicals was studied with respect to both peroxidase substrates, o-anisidine and hydrogen peroxide. Initial velocities of o-anisidine oxidation by HRP under various conditions were determined spectrophotometrically. RESULTS: The CYP inhibitors metyrapone, troleandomycine, disulfiram, sulfaphenazole, quinidine and 1-aminobenzotriazole do not inhibit o-anisidine oxidation catalyzed by HRP. In contrast, ketoconazole, diethyldithiocarbamate, ellipticine, α-naphtoflavone, proadifen SKF525A, piperonylbutoxide, were found to inhibit not only the CYPs, but also the HRP-mediated oxidation of o-anisidine. Interestingly, α-naphtoflavone inhibits oxidation of o-anisidine by HRP with respect to H2O2, but not with respect to o-anisidine. Diethyldithiocarbamate is the most potent peroxidase inhibitor of o-anisidine oxidation with Ki with respect to o-anisidine of 10 μM and Ki with respect to H2O2 of 60 μM, being even the better peroxidase inhibitor than the classical "peroxidase inhibitor" - propyl gallate (Ki with respect to o-anisidine of 60 μM and Ki with respect to H2O2 of 750 μM). CONCLUSIONS: The results of the present study demonstrate that 1-aminobenzotriazole, a potent inhibitor of various CYP enzymes, seems to be the best candidate suitable for utilization in studies evaluating participation of CYP enzymes in metabolism of xenobiotics in various complex biological materials containing both CYP and peroxidase enzymes. Moreover, precaution to prevent misinterpretation of results is necessary in cases when proadifen SKF525A, piperonylbutoxide, diethyldithiocarbamate, ketoconazole, α-naphtoflavone and ellipticine are used in similar studies (as CYP inhibitors in various complex biological materials containing both CYP and peroxidase enzymes), since these chemicals can except of CYP enzymes inhibit also peroxidase-mediated reactions.
650    _2
$a benzoflavony $x chemie $x farmakologie $7 D001571
650    _2
$a systém (enzymů) cytochromů P-450 $7 D003577
650    _2
$a disulfiram $x chemie $x farmakologie $7 D004221
650    _2
$a dithiokarb $x chemie $x farmakologie $7 D004050
650    _2
$a elipticiny $x chemie $x farmakologie $7 D004611
650    _2
$a aktivace enzymů $x účinky léků $7 D004789
650    _2
$a inhibitory enzymů $x chemie $x farmakologie $7 D004791
650    _2
$a křenová peroxidasa $x antagonisté a inhibitory $x metabolismus $7 D006735
650    _2
$a lidé $7 D006801
650    _2
$a ketokonazol $x chemie $x farmakologie $7 D007654
650    _2
$a metyrapon $x chemie $x farmakologie $7 D008797
650    _2
$a piperonylbutoxid $x chemie $x farmakologie $7 D010882
650    _2
$a proadifen $x chemie $x farmakologie $7 D011335
650    _2
$a chinidin $x chemie $x farmakologie $7 D011802
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a substrátová specifita $x účinky léků $7 D013379
650    _2
$a sulfafenazol $x chemie $x farmakologie $7 D013426
650    _2
$a triazoly $x chemie $x farmakologie $7 D014230
650    _2
$a troleandomycin $x chemie $x farmakologie $7 D014217
650    _2
$a inhibitory cytochromu P450 $7 D065607
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kubickova, Bozena $u -
700    1_
$a Stiborova, Marie $u -
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 3(2012), s. 33-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23353841 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20131002123613 $b ABA008
999    __
$a ok $b bmc $g 987684 $s 822384
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 33 Suppl 3 $d 33-40 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...